Methodology Report

Nonviral Gene Delivery to Mesenchymal Stem Cells Using Cationic Liposomes for Gene and Cell Therapy

Table 1

Percentage of MSC viability and recovery at different passages (1–7), 24 hours after transfection. Controls are non-transfected cells. Results are presented as 𝑚 𝑒 𝑎 𝑛 ± 𝑠 𝑡 𝑎 𝑛 𝑑 𝑎 𝑟 𝑑 deviation of duplicates.

Passage numberCell Viability (%)Cell Recovery (%)
ControlTransfected cellsTransfected cells

190.1 ( ± 3.3)93.6 ( ± 3.8)52.5 ( ± 11.2)
291.5 ( ± 3.1)89.7 ( ± 8.0)80.4 ( ± 33.6)
485.5 ( ± 4.1)89.7 ( ± 1.7)98.0 ( ± 11.5)
586.6 ( ± 6.1)92.4 ( ± 0.6)79.1 ( ± 6.3)
694.1 ( ± 2.9)94.7 ( ± 1.9)74.2 ( ± 5.5)
791.4 ( ± 0.4)91.1 ( ± 9.2)88.0 ( ± 4.6)